WhiteLab Genomics Company
WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.
Connections from
Total Funding:
10500000
Founded Date:
2019-01-01
Industry:
Quantum Biology
Employee Number:
11-50
Last Funding Date:
2022-09-12
Funding Status:
private
Headquarters:
Paris,Ile-de-France,France,Europe
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
10500000
Last Funding Total Usd:
10000000
Last Funding Total Currency:
USD
Last Funding Total Value:
10000000
Founders:
Cedric Odje,David Delbourgo,Julien Cottineau